Who is sponsoring NCT00376662?

NCT00376662 is sponsored by British Thoracic Society.

What condition does NCT00376662 study?

NCT00376662 studies Osteoporosis.

What drugs are being tested in NCT00376662?

Interventions: Hormone Replacement Therapy and Etidronate.

What is the status of NCT00376662?

NCT00376662 is currently COMPLETED.

Last reviewed 2006-09-13 · How we verify

HRT and/or Etidronate in the Prevention and Treatment of Osteoporosis and Fractures in Post-Menopausal Patients With Asthma Receiving Long-Term Oral and/or Inhaled Glucocorticoids:a Randomised Factorial Trial

NCT00376662 Phase 4 COMPLETED

To determine and compare the effects of Hormone replacement therapy (HRT), etidronate, HRT plus etidronate and no treatment over 5 years in the prevention and treatment of glucocorticoid-induced osteoporosis and fractures in post-menopausal women with asthma.

Details

Lead sponsor	British Thoracic Society
Phase	Phase 4
Status	COMPLETED
Enrolment	750
Start date	1992-08
Completion	2000-10

Conditions

Osteoporosis

Interventions

Hormone Replacement Therapy and Etidronate

Primary outcomes

New symptomatic fractures, new or worsening morphometric fractures of the throaco-lumbar spine, and changes in bone mineral density.

Countries

United Kingdom